rs5958217

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_007325.5(GRIA3):​c.509-29755G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.77 ( 22642 hom., 24861 hem., cov: 23)
Failed GnomAD Quality Control

Consequence

GRIA3
NM_007325.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0190

Publications

0 publications found
Variant links:
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
GRIA3 Gene-Disease associations (from GenCC):
  • syndromic X-linked intellectual disability 94
    Inheritance: XL Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability due to GRIA3 anomalies
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007325.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007325.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIA3
NM_000828.5
MANE Plus Clinical
c.509-29755G>A
intron
N/ANP_000819.4P42263-1
GRIA3
NM_007325.5
MANE Select
c.509-29755G>A
intron
N/ANP_015564.5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIA3
ENST00000620443.2
TSL:1 MANE Select
c.509-29755G>A
intron
N/AENSP00000478489.1P42263-2
GRIA3
ENST00000622768.5
TSL:5 MANE Plus Clinical
c.509-29755G>A
intron
N/AENSP00000481554.1P42263-1
GRIA3
ENST00000620581.4
TSL:1
n.509-29755G>A
intron
N/AENSP00000481875.1A0A087WYJ6

Frequencies

GnomAD3 genomes
AF:
0.767
AC:
84017
AN:
109563
Hom.:
22655
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.723
Gnomad AMI
AF:
0.786
Gnomad AMR
AF:
0.808
Gnomad ASJ
AF:
0.815
Gnomad EAS
AF:
0.934
Gnomad SAS
AF:
0.877
Gnomad FIN
AF:
0.760
Gnomad MID
AF:
0.825
Gnomad NFE
AF:
0.766
Gnomad OTH
AF:
0.766
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.767
AC:
84049
AN:
109613
Hom.:
22642
Cov.:
23
AF XY:
0.773
AC XY:
24861
AN XY:
32159
show subpopulations
African (AFR)
AF:
0.723
AC:
21863
AN:
30257
American (AMR)
AF:
0.807
AC:
8257
AN:
10226
Ashkenazi Jewish (ASJ)
AF:
0.815
AC:
2137
AN:
2622
East Asian (EAS)
AF:
0.934
AC:
3232
AN:
3460
South Asian (SAS)
AF:
0.876
AC:
2251
AN:
2569
European-Finnish (FIN)
AF:
0.760
AC:
4407
AN:
5798
Middle Eastern (MID)
AF:
0.822
AC:
176
AN:
214
European-Non Finnish (NFE)
AF:
0.766
AC:
40037
AN:
52285
Other (OTH)
AF:
0.769
AC:
1157
AN:
1505
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
736
1472
2209
2945
3681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
718
1436
2154
2872
3590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.773
Hom.:
37487
Bravo
AF:
0.772

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.6
DANN
Benign
0.80
PhyloP100
-0.019
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5958217;
hg19: chrX-122430122;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.